Shire plc Tries to Sell Its ADHD Pill in Europe, But Will Anyone Pay Attention?

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

The pharmaceutical industry may have a hard time gaining attention in Europe for one of its best-selling categories in the US – the pills that are widely prescribed to combat attention deficit hyperactivity disorder, or ADHD. Why? Many Europeans are not convinced that ADHD really exists and do not want to use medication for what is widely viewed as childhood behavior problems, Bloomberg News writes.

Help employers find you! Check out all the jobs and post your resume.

Back to news